Recent Articles from Investor Brand Network

New York Governor Kathy Hochul signed the state’s latest budget into law on Friday, but one key proposal that had stirred significant backlash didn’t make it into the final version. Earlier this year, Hochul had proposed allowing police to use the smell of cannabis as a reason to suspect a driver of being under the influence and require them to undergo a drug test.

Aston Bay (TSX.V: BAY) (OTCQB: ATBHF), through its joint venture with American West Metals, has secured a strategic partnership with Ocean Partners Holdings to significantly advance the Storm Copper Project in Nunavut, Canada. The deal includes up to 80% project development financing and a binding offtake agreement granting Ocean Partners exclusive rights to copper and silver products from near-surface mineralization. Backed by a US$3.5 million second tranche payment from Taurus Mining Royalty and C$0.996 million to Aston Bay, the funding will support aggressive exploration and pre-feasibility efforts in 2025.

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) is scheduled to report its first quarter 2025 financial results after the market closes on Thursday, May 15. A conference call and webcast will follow at 4:30 p.m. ET, accessible via the company’s investor relations site or by dialing +1-800-717-1738 (U.S.) or +1-646-307-1865 (international).

Cannabis Means Business (“CMB”) today announced that Whoopi Goldberg will participate in a fireside chat and launch her new hemp-derived beverage, Whoop-Tea, at CMB 2025 , taking place on June 4–5 at the Javits Center in New York City . The Emmy, Grammy, Oscar, and Tony Award-winning entertainer and entrepreneur will join CNBC’s Tim Seymour on Wednesday, June 4 , for an exclusive conversation in the Special Events Area on the CMB exhibit floor. The discussion will delve into the fast-rising cannabis beverage market and the vision behind Whoop-Tea , created in collaboration with leading cannabis beverage brand Pure Genesis .

Sustain Southern California (“Sustain SoCal”) has announced its upcoming event, Agriculture, Food Systems and Waste Stream Innovations, slated to take place in Irvine, California, on Thursday, May 15, 2025. The synergistic agenda will drive comprehensive discussions along the entire spectrum of the supply chain, from agtech, farm-to-table, packaging innovations, and waste management policy.

SurgePays (Nasdaq: SURG) has entered into a $7 million senior secured convertible note agreement with a current institutional shareholder, providing $6 million in cash and involving a repurchase of 333,333 shares. The two-year note is convertible into common stock at $4.00 per share, a premium to current market price, and includes a prepayment option at a 2% premium. Proceeds will support the national launch of LinkUp Mobile and the growth of SurgePays’ MVNE wholesale platform following its April 1 integration with AT&T. Management projects over $200 million in revenue and positive cash flow from operations by year-end 2025.

NanoViricides, Inc. (NYSE American: NNVC) provided a strategic update on its antiviral pipeline, highlighting NV-387 as a potential breakthrough treatment for Measles and MPox amid rising global case counts and vaccine failures. The company has begun preparations for animal efficacy studies for Measles and will make NV-387 available under FDA’s Individual Patient Expanded Access. In the DRC, its Phase II Clinical Trial Application for MPox has been cleared by the national ethics committee. NV-387 is also being developed for broad respiratory infections in a basket trial format and for pan-herpesvirus treatment. With no current approved drugs for Measles or MPox, NanoViricides aims to fill critical gaps in global antiviral preparedness.

When most people think about electric cars, China isn’t the first name that comes to mind, but maybe it should be. Toyota has just sounded the alarm, and it’s not just about electric vehicles anymore. According to the company, China’s rise in the auto world is happening fast and across more than one area.

A viral video on social media platform TikTok is popularizing a quick and easy hand test that can reportedly reveal if someone has an undiagnosed brain tumor . The British medic who demonstrated the 30-second test on the TikTok account claims that it can help individuals identify serious brain health issues that haven’t been diagnosed yet.

Silo Pharma (NASDAQ: SILO) has partnered with Frontage Laboratories to conduct a 7-day safety and toxicology study of its lead asset, SPC-15, following a request from the FDA. The intranasal treatment targets PTSD and stress-related disorders, and the study is expected to strengthen Silo’s upcoming IND application. Silo remains on track for an FDA submission this year and is concurrently running a GLP-compliant toxicology study. SPC-15, developed in collaboration with Columbia University, is a 5-HT4 receptor agonist potentially eligible for the FDA’s 505(b)(2) pathway.

Knightscope (NASDAQ: KSCP) reported Q1 2025 revenue of $2.9 million, up 29% year-over-year, while net loss narrowed to $6.9 million, a 19% improvement. The company improved gross margin loss to (23%) from (64%) and cut G&A expenses by 24%. Knightscope ended the quarter with $12.7 million in cash and a $2.5 million backlog. Strategic initiatives included securing a 33,000-square-foot headquarters in Sunnyvale, California, and raising $8.8 million in equity offerings. The company will present at the Ladenburg Thalmann Innovation EXPO25 on May 21 in New York.

Massimo (NASDAQ: MAMO) is entering a new growth phase with the launch of a comprehensive digital retail platform. This move, announced in April 2025, is designed to simplify the purchasing process for its UTVs, ATVs, and mini-bikes, while expanding the company’s national sales footprint.

ESGold (CSE: ESAU) (OTCQB: ESAUF) President Brad Kitchen appeared on the latest episode of The MiningNewsWire Podcast to discuss the company’s fully permitted Montauban project and near-term path to gold and silver production. Kitchen emphasized ESGold’s unique model of funding exploration through early-stage tailings production, citing an estimated $100 million in recoverable material from the historic mine. He also highlighted the project’s community impact, operational goals for 2025, and a tightly aligned marketing plan to increase visibility as production ramps.

Tonix Pharmaceuticals (NASDAQ: TNXP) has appointed Joseph Hand, Esq., as General Counsel and Executive Vice President of Operations. Hand brings decades of leadership experience across legal, HR, and corporate services, including a pivotal role in Celgene’s $74 billion acquisition by Bristol Myers Squibb and the $13.4 billion divestiture of Otezla® to Amgen. His addition comes as Tonix prepares for a potential launch of TNX-102 SL for fibromyalgia, pending FDA approval.

HeartBeam (NASDAQ: BEAT) reported Q1 2025 results highlighted by successful completion of the VALID-ECG pivotal study, supporting its 510(k) submission for 12-lead ECG synthesis software and confirming productive ongoing FDA discussions. The company launched an Early Access Program, signed a strategic partnership with AccurKardia to integrate its FDA-cleared AccurECG(TM) software, added two new U.S. patents to bring its IP total to 20, appointed CEO Robert Eno to its board, and raised $11.5 million through a public offering to support commercialization plans.

FAVO Capital (OTC: FAVO), a provider of revenue-based funding solutions for SMBs, announced its participation in the D. Boral Capital Inaugural Global Conference on May 14, 2025, at The Plaza Hotel in New York City. President Shaun Quin will represent the company in meetings with institutional investors, highlighting FAVO’s growth strategy and IPO readiness. CEO Vincent Napolitano emphasized the event as a key platform to expand visibility and engage potential investors ahead of the company’s planned uplisting.

Cybin (NYSE American: CYBN) (NEO: CYBN) announced that CEO Doug Drysdale will participate in a fireside chat at the virtual Alliance Global Partners Healthcare Company Showcase on May 21, 2025. The session will be webcast live at 1:40 p.m. ET and later available via the company’s investor relations site.

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company focused on brain and central nervous system cancers, has priced a “reasonable best efforts” public offering with a single healthcare-focused institutional investor, raising approximately $5 million in gross proceeds. The offering includes 3,952,570 shares of common stock at $1.265 per share and accompanying Series F warrants to purchase an equal number of shares at $1.14 per share, exercisable immediately and valid for five years. A.G.P./Alliance Global Partners is acting as the sole placement agent. Proceeds will be used for working capital and general corporate purposes. Closing is expected on or about May 14, 2025.

Annovis Bio (NYSE: ANVS) initiated its pivotal Phase 3 clinical trial in early Alzheimer’s disease during Q1 2025, with enrollment now underway for up to 760 participants to assess buntanetap’s symptomatic and disease-modifying effects over 18 months. The company also secured a new U.S. patent for buntanetap and participated in several key scientific and investor conferences, including Oppenheimer’s 35th Annual Healthcare Life Sciences Conference and AD/PD(TM) 2025 in Vienna. Cash and equivalents rose to $22.2 million as of March 31, 2025, while R&D expenses fell year-over-year to $5.0 million.

SOBRsafe (NASDAQ: SOBR) has appointed Kris Pederson, a veteran corporate director with leadership roles at EY, IBM (NYSE: IBM), and PwC, to its Board of Directors effective May 1, 2025, where she will also chair the Nominating and Corporate Governance Committee. The Company also named Dr. Benjamin Sanchez as a Scientific Advisor in February to support federal funding and clinical research partnerships. The additions bring deep expertise in governance, digital innovation, and biomedical engineering as SOBRsafe continues scaling its alcohol detection technology platform.

Ucore Rare Metals (TSXV: UCU) (OTCQX: UURAF) is nearing the commissioning of its RapidSX(TM) Commercial Demonstration Plant in Kingston, Ontario, a key milestone in its plan to commercialize its advanced rare earth element (REE) separation technology. The company is also preparing to construct its first Strategic Metals Complex (SMC) in Louisiana, expected to process 2,000 tons of total rare earth oxides by the end of 2024 and scale to 5,000 tons in 2026. Ucore’s long-term roadmap includes additional SMCs in Alaska and Canada, alongside the development of its 100%-owned Bokan-Dotson Ridge HREE resource in Alaska. With strong U.S. and Canadian government support and partnerships with Kingston Process Metallurgy and Mech-Chem Associates, Ucore aims to establish a complete North American REE supply chain independent of China.

Artificial intelligence (“AI”) is rapidly transforming the marketing landscape, enabling businesses to deliver more personalized, efficient and data-driven campaigns. As companies seek to harness the power of AI to stay competitive, ONAR Holding Corp. (OTCQB: ONAR) is at the forefront with its innovative Cortex platform, poised to redefine the future of advertising.

The nickel mining industry in Indonesia has reacted negatively to the government’s increase of mining royalties from 10% to rates that vary from 14-19%. The change took effect at the start of May. The government is looking at these increased royalties as a source of needed revenue to fund the ambitious programs initiated by President Subianto. For example, he started a program to offer free meals for pregnant mothers and children. He has also established a sovereign wealth fund for the country.

SKYX Platforms (NASDAQ: SKYX), a smart home platform technology company with over 97 issued and pending patents, announced it has raised approximately $4 million from strategic investors through preferred stock priced at $2.00 per share. The investment is part of a broader $15 million financing round led by The Shaner Group, with additional participation from SKYX insiders including President Steve Schmidt and Co-CEOs Lenny Sokolow and John Campi. The funding will support general working capital and corporate initiatives as the company advances its home innovation platform and e-commerce portfolio.

President Donald Trump has announced that he’s pulling his nomination for Ed Martin, who was set to become the U.S. attorney for Washington, D.C.

MoneyShow, a leading producer of live and online financial conferences for investors, traders, and financial advisors, today announced the upcoming “ Navigating Volatility, Finding Opportunity: A Virtual Expo ,” set to take place May 21-22, 2025. “Investors face several key issues in this market environment. They include far-reaching U.S. tariffs, geopolitical tensions, inflation concerns, evolving trade dynamics, the potential for interest rate cuts, and the surge in safe-haven assets,” said MoneyShow’s Editor-in-Chief Mike Larson. “Our star-studded line-up of speakers will provide attendees with in-depth context to the latest market moves. They will also share highly actionable insights on minimizing risks in choppy seas, maximizing profit avenues, and repositioning portfolios to manage uncertainty across the second half of the year.”

Mullen Automotive (NASDAQ: MULN), an electric vehicle manufacturer, announced it has executed a settlement agreement with GEM Yield Bahamas Limited and GEM Global Yield LLC SCS, resolving a four-year legal dispute. Under the agreement, GEM has a 55-day due diligence period—subject to extension—to evaluate the transfer of Mullen’s Mishawaka assets in full satisfaction of the judgment. All collection activities will be suspended during this period. Mullen stated it remains focused on expanding its Tunica, Mississippi, manufacturing operations to meet growing demand across its EV product lines.

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0), a Swiss-hosted cybersecurity and private communications platform, has initiated discussions with multiple referral partners to launch its privacy-focused solutions across several African countries. The move targets enterprise and government clients, especially in high-risk sectors such as education, telecom, and public administration, in response to the continent’s growing exposure to cyber threats. Sekur’s communications suite, which includes encrypted email, messaging, and VPN services, will soon feature multi-tiered authorization for added enterprise security. All services are hosted in Switzerland under strict federal data protection laws, supporting Sekur’s commitment to global privacy standards.

The largest contract electronics manufacturer in the world has teamed up with Mitsubishi to develop and manufacture electric cars for the Japanese automaker. Foxconn, also referred to as Hon Hai Technology Group, has been seeking opportunities to enter the burgeoning electric vehicle sector for quite some time. The world-leading electronics manufacturer now appears to have completed its years-long quest to enter electric vehicle development.

A recent report by energy technology company Baker Hughes reveals that U.S. energy firms have slashed the number of active oil and natural gas rigs to their lowest levels since the beginning of the year. According to the report, the number of oil rigs fell to 474, while natural gas rigs remained unchanged.

A recently conducted study has found a strong link between the intake of ultra-processed foods (UPFs) and a higher risk of developing psoriasis. The findings of this research appeared in the Nutrients journal.

European fashion e-commerce giant Zalando is using generative AI to create images for its website and app more quickly, reflecting how artificial intelligence is changing the fashion industry and helping businesses cut costs.

FAVO Capital (OTC: FAVO), a private credit firm focused on merchant cash advances and revenue-based financing for underserved SMBs, announced the voluntary conversion of all outstanding Super Voting Series C Preferred Shares into common stock. The move simplifies the company’s capital structure, eliminates super voting rights, and aligns with public market governance standards as FAVO continues its preparations for a planned uplisting to the Nasdaq Capital Market. CEO Vincent Napolitano said the decision reflects FAVO’s commitment to transparency, best practices, and long-term value creation for shareholders.

ONAR (OTCQB: ONAR), a global marketing technology firm specializing in AI-driven solutions for revenue acceleration, has selected IBN to lead its corporate communications initiatives. ONAR, which operates across performance, healthcare, and experiential marketing, aims to redefine middle-market marketing through innovation and strategic acquisitions. The company is rapidly growing its global footprint and integrating specialized agencies under one brand to deliver superior client outcomes. Through this partnership, IBN will deploy its expansive distribution network—including 5,000+ syndication outlets and millions of followers across 70+ brands—to amplify ONAR’s visibility among investors and the broader market.

As the opioid crisis continues to challenge public health systems, the need for innovative solutions has become increasingly apparent. Rather than relying solely on restrictive measures, companies such as Nutriband (NASDAQ: NTRB) are exploring technological advancements to mitigate abuse while ensuring patient access to necessary medications. Nutriband’s development of AVERSA(TM) Fentanyl, an abuse-deterrent transdermal patch, exemplifies this forward-thinking approach ( https://ibn.fm/jhHMY ).

Oragenics (NYSE American: OGEN) a biotechnology company developing intranasal therapies for brain-related disorders, announced it has received approval from Australia’s Human Research Ethics Committee (“HREC”) to begin a Phase II clinical trial of ONP-002, its proprietary neuroprotective therapy for mild traumatic brain injury (mTBI), or concussion. The clearance enables the company to initiate patient enrollment as early as Q2 2025 at Level 1 trauma emergency departments, where concussed patients are often treated. ONP-002, a non-invasive intranasal formulation, has demonstrated safety in Phase I and efficacy in preclinical models by reducing inflammation, oxidative stress and brain swelling. CEO Janet Huffman said the approval marks a key step toward expanding the ONP-002 program internationally, with enrollment sites also under consideration in New Zealand.

Tonix Pharmaceuticals (NASDAQ: TNXP), a fully-integrated biopharmaceutical company, announced financial results for the first quarter of 2025 and reaffirmed its focus on the anticipated FDA decision for TNX-102 SL, a non-opioid analgesic for fibromyalgia, with a PDUFA goal date of Aug. 15. If approved, it would mark the first new drug class for fibromyalgia in more than 15 years. Tonix also highlighted progress across its pipeline, including positive Phase 1 data for TNX-1500 in kidney transplant rejection and strong preclinical results for TNX-801, a live-virus vaccine targeting mpox and smallpox. The company ended the quarter with $131.7 million in cash and cash equivalents and reported a net loss of $16.8 million on $2.4 million in product revenue.

G Mining Ventures Corp. (TSX: GMIN) (OTCQX: GMINF) announced plans to restate its 2024 consolidated financial statements and Management Discussion and Analysis due to two non-cash accounting adjustments totaling approximately $32 million related to IAS 21 foreign exchange treatment. The restatement, which has no impact on the company’s cash position, operations, or financial covenants, reclassifies $11 million in unrealized foreign exchange losses and $21 million in income tax recovery. Net income for Q4 2024 will be restated from $47.6 million to $15.2 million, and basic EPS from $0.21 to $0.07. Revised documents will be filed before the company releases Q1 2025 results on May 14, with a conference call scheduled for May 15.

Intelligent Bio Solutions (Nasdaq: INBS), a medical technology company delivering rapid, non-invasive testing solutions, reported a 20% sequential revenue increase to $728,867 in fiscal Q3 2025, driven by growth in cartridge sales, which now account for 58% of total revenue and strengthen its recurring revenue model. Gross profit surged 91% year-over-year to $341,368, while net loss narrowed by $434,141 to $2.54 million. INBS added 35 new accounts, bringing its active customer base to over 450, and continued expanding internationally through partnerships and multilingual system upgrades. The company also secured its sixth U.S. patent and advanced regulatory efforts across key global markets.

CNS Pharmaceuticals (NASDAQ: CNSP) announced the successful transfer of Orphan Drug Designation from Cortice Biosciences for its lead asset TPI 287, covering gliomas, pediatric neuroblastoma, and progressive supranuclear palsy. TPI 287, a microtubule-stabilizing abeotaxane, has shown potential to cross the blood-brain barrier and demonstrated encouraging results in a Phase 1 glioblastoma trial, including 3 complete and 9 partial responses among 23 evaluable patients. The company plans to initiate a Phase 2 study by year-end 2025 and highlighted the potential benefits of Orphan status, including seven years of market exclusivity upon approval.

SKYX Platforms (NASDAQ: SKYX), doing business as “SKYX Technologies,” announced it will host a corporate update call to review its first quarter 2025 financial results on Wednesday, May 14, at 4:30 p.m. ET. The call will feature Founder and Executive Chairman Rani Kohen, President Steve Schmidt (former CEO of Nielsen Data Corporation and President of Office Depot International), Co-CEO Lenny Sokolow, and CFO Marc Boisseau. The company is known for its disruptive advanced and smart home platform technologies and holds more than 97 issued and pending patents globally, along with a portfolio of over 60 lighting and home décor websites.

Brera Holdings (NASDAQ: BREA), an Ireland-based, international holding company focused on expanding its global portfolio of men’s and women’s sports clubs through a multi-club ownership (“MCO”) approach, has emphasized its commitment to the evolving model of sustainable football investment, something it believes is integral to long-term value creation ( https://ibn.fm/YaGK8 ).

The crypto sector has just hit its first major obstacle under Donald Trump’s second term after enjoying a period of unprecedented support in Washington. Senate Democrats recently blocked a crypto measure that had strong backing from the industry, signaling a shift in momentum on Capitol Hill. While the proposal isn’t entirely off the table, its path forward is uncertain, especially as political divisions deepen.

A recent report has revealed that while renewable energy production in the U.S. has tripled in the past decade, its progress is being threatened by the Trump administration’s policies . Renewable energy projects in the U.S. are producing more clean energy than ever, but political uncertainty under President Donald Trump and billions of dollars in budget cuts could dampen America’s progress.

Mazda has officially announced that its future electric vehicles (EVs) in Japan will use the North American Charging Standard (NACS), which was developed by Tesla. Starting from 2027, new Mazda EVs sold in Japan will be built with NACS charging ports.

NRx Pharmaceuticals (NASDAQ: NRXP) announced that its wholly owned subsidiary, HOPE Therapeutics(TM), has signed a definitive agreement to acquire the Kadima Neuropsychiatry Institute. Kadima, a leading California clinic for interventional psychiatry, offers treatments such as ketamine, Spravato, transcranial magnetic stimulation (TMS), and medication management for CNS disorders including suicidal depression and PTSD. The clinic is profitable and expected to serve as the clinical model for future HOPE clinics. Dr. David Feifel, Kadima’s founder and a nationally recognized leader in interventional psychiatry, will join HOPE as its first Chief Medical Innovation Officer following the closing of the acquisition, which remains subject to customary conditions and financing.

A measure now moving through Pennsylvania’s State House could make cannabis available in stores overseen by the state. On Monday, House Democrats narrowly approved the measure in the Health Committee with a 14-12 vote.

Aegis Capital is pleased to announce its role as the sole book-running manager in the recently completed underwritten public offering for Super League Enterprise, Inc. (NASDAQ: SLE). The offering comprised 5,117,647 shares of common stock at a public offering price of $0.17 per share, resulting in gross proceeds of approximately $869,999 before underwriting fees and expenses. The company also granted Aegis a 45-day overallotment option to purchase up to an additional 767,647 shares, which could increase total gross proceeds to $1 million if fully exercised.

Cannabis Means Business (“CMB”), the industry’s premier business-to-business conference and expo, today shared new details on its schedule of panels and presentations, as well as programming, exhibitions and networking opportunities. The expo will feature a lineup of engaging speakers, including CNBC Fast Money trader Tim Seymour, Philip Wolf, a pioneer of the cannabis hospitality sector. and Dr. Chanda Macias, CEO of Women Grow.

IBN (InvestorBrandNetwork), a multifaceted communications organization committed to connecting companies with the investment community through its dynamic portfolio of 60+ brands, today announced its engagement as the official media partner for DealFlow Events’ inaugural DealFlow Discovery Day on Nuclear Energy . The event is slated to take place on May 22, 2025, at the conveniently located Jay Suites in New York City.

It is very natural to feel immense anxiety and fear after receiving a breast cancer diagnosis. Most people don’t consider seeking second opinions and would rather begin treatment right away. After all, breast cancer is one of the deadliest types of cancer in women, second only to lung cancer in terms of fatalities. The Breast Cancer Research Foundation estimates that slightly over 42,000 women will die from the condition in 2025, making it one of the most prolific killers in the USA.

The year 2024 was a big one for solar power. All around the world, countries worked hard to add new solar energy systems. By the end of the year, nearly 600 gigawatts (GW) of new solar power had been installed. This was a record-breaking number and showed how fast the world is turning to clean energy.

SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the U.S., has announced a US$100 million project-based financing with infrastructure investor CIM Group to fund a 97 MW portfolio of solar energy projects in the United States. The deal marks a significant step in SolarBank’s evolution from solar developer to long-term asset owner, offering equity-style exposure to U.S. renewable energy growth without issuing new shares ( https://ibn.fm/J7XIZ ).

Nightfood Holdings (OTCQB: NGTF) announced the signing of a Letter of Intent to acquire the 120-room Hilton Garden Inn in Rancho Mirage, California for $36.93 million, marking one of the company’s largest deals to date. The hotel, adjacent to Disney’s Cotino(TM) residential resort community, will serve as a flagship site for Nightfood’s AI-powered Robotics-as-a-Service (“RaaS”) platform, which aims to reduce labor costs and enhance operational efficiency. The acquisition includes plans for a five-room expansion, a $3 million earn-out, and $26.43 million in Series C Preferred Stock, contingent on financial audits, mortgage conditions, and uplisting to a national exchange.

NRx Pharmaceuticals (NASDAQ: NRXP) announced it will release its first quarter 2025 financial results after market close on Thursday, May 15, 2025. The company will host a conference call at 4:30 p.m. ET the same day to discuss the results and provide a corporate update.

IBN, is pleased to announce the latest CryptoCurrencyWire audio production featuring Andrew Gordon, Managing Attorney of Gordon Law Group, a firm that focuses on helping individuals and businesses navigate the intricate world of digital asset taxation, including NFTs and DeFi. In the interview, Gordon outlines key steps for maintaining tax compliance in the crypto space, stressing that investors using multiple exchanges must take responsibility for gathering and organizing all relevant records. He notes that recordkeeping is a basic but crucial element of compliance, especially in a space where standardization across platforms is lacking.

Platinum Group Metals (NYSE American: PLG) (TSX: PTM) announced plans to raise approximately $1.01 million through a private placement of 800,000 common shares at $1.26 per share to major shareholder Hosken Consolidated Investments Limited (“HCI”), pending regulatory approval. The proceeds will support the company’s share of pre-construction activities at the Waterberg Project in South Africa and general corporate needs. The placement price reflects a 3.1% premium to the five-day VWAP on NYSE American as of May 9. Upon completion, HCI will return to a 26% ownership stake. The shares will be subject to a four-month-plus-one-day resale restriction and were offered under exemptions to registration and shareholder approval requirements due to HCI’s related-party status.

Oragenics (NYSE American: OGEN) will host a management update webinar on Tuesday, May 20, 2025, at 4:00 p.m. ET to discuss the unmet medical need in concussion treatment and highlight its lead candidate, ONP-002. The intranasal therapy is currently in a Phase IIa trial for mild traumatic brain injury and has shown promising preclinical results in reducing brain inflammation and swelling. Presenters will include CEO Janet Huffman, CMO Dr. James Kelly, and Chief Clinical Officer Dr. Frank Peacock, a national emergency medicine expert.

NUBURU (NYSE American: BURU) has received a Notice of Noncompliance from NYSE Regulation for failing to meet the $2 million stockholders’ equity requirement under Section 1003(a)(i) of the NYSE American Company Guide, following continued operating losses and a going concern warning in its latest 10-K. The notice does not immediately impact BURU’s trading status, though its ticker now carries a “.BC” designation. The company has until May 29 to submit a plan to regain compliance and until Oct. 29, 2026 to meet the listing standards. Management cited recent strategic initiatives as potential paths to compliance, though their success is not guaranteed.

Copper inventories on the SHFE (Shanghai Futures Exchange) are forecast to further reduce at the end of this week. The quick drop in supplies is expected to trigger a rise in prices, which could incentivize traders to resume shipping the metal to China.

Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) is a critical metals (“CM”) separation technology company executing an ESG-centered plan toward establishing a comprehensive North American critical metals supply chain. The company has developed a transformative commercial-ready technology, RapidSX(TM), for separating and purifying critical metals. Ucore intends to deploy this technology in pursuit of a CM supply chain independent of China for Western original equipment manufacturers (“OEMs”), most notably in the automotive and renewable energy industries.

Quantum BioPharma (NASDAQ: QNTM) announced the completion of dosing in 90-day oral toxicity and toxicokinetic studies for its lead candidate Lucid-21-302 (“Lucid-MS”), a novel treatment in development for multiple sclerosis. The results of these studies will support an Investigational New Drug (IND) application to the U.S. FDA, expected by year-end. Executives highlighted the milestone as a major step toward launching a Phase 2 clinical trial and positioning Lucid-21-302 as a first-in-class therapy for MS.

Wheaton Precious Metals (NYSE: WPM) (TSX: WPM) delivered record quarterly revenue of $470 million in Q1 2025, up 58.5% year over year, driven by a 36% increase in average realized gold equivalent prices and a 16% rise in GEOs sold. Adjusted net earnings rose 53% to $250.8 million, with operating cash flow climbing 64.5% to $361 million. The company declared a 6.5% dividend increase to $0.165 per share and highlighted its robust growth outlook, with four development projects expected to begin production in 2025. Wheaton ended the quarter with $1.1 billion in cash and no debt, supporting its ongoing expansion strategy and capital commitments.

New research shows that using cannabis while pregnant can put both the mother and baby at serious risk. A large-scale review of past studies found links between prenatal cannabis use and problems like low birth weight, premature birth, and even infant death.

Platinum Group Metals (NYSE American: PLG) (TSX: PTM) is advancing the development of its Waterberg Project in South Africa, a large-scale platinum group metals (“PGM”) mine expected to be among the world’s largest and lowest-cost underground operations. In September 2024, an independent definitive feasibility study (“DFS”) was completed for Waterberg, highlighting its robust economics, including projected steady state annual production of 353,208 ounces of platinum, palladium, rhodium and gold, along with significant copper and nickel by-products, over a 54-year mine life. Located in the Bushveld Complex, the project features thick, shallow ore bodies allowing for safer, more efficient mining. Amid rising global demand for PGMs—especially in automotive, electronics, and clean energy sectors—Platinum Group Metals is strategically positioned to meet future market needs.

Calidi Biotherapeutics (NYSE American: CLDI) recently announced promising preclinical results for its innovative RTNova platform, which has successfully delivered transient gene-therapy payloads to targeted tumors. In addition, Calidi’s virotherapy demonstrated efficacy in killing more than 60 different tumor cell lines, showcasing the platform’s potential to revolutionize cancer treatment by enabling both tumor destruction and robust immune activation.

DealFlow Events today announced the launch of the inaugural DealFlow Discovery Day on Nuclear Energy, slated to take place in New York City on May 22, 2025. The event provides a forum for discovering new investment opportunities and exchanging ideas with industry stakeholders including utilities, financiers, site developers, technology providers, and government entities. Especially timely in light of the renaissance in the nuclear energy sector on the back of strong demand for clean energy and the intensive operations of data centers and AI technologies, the event will feature an insights-packed agenda. Thought leaders and top management of companies in the sector will share first-hand perspectives on a variety of pertinent industry topics, including business models, sectoral opportunities and challenges, and avenues of future expansion. The platform provides a unique opportunity for CEOs and senior leadership teams to showcase their companies to professional investors.

NUBURU (NYSE American: BURU) has announced the formation of a strategic working group to revitalize its Blue-Laser Business Unit, aiming to strengthen its position in the defense sector. The move follows a Joint-Pursuit Agreement with a defense-tech partner and plans to introduce vertical applications that enable cross-selling to existing and new clients. NUBURU is also advancing discussions to bring in a senior revenue and marketing strategist, while leveraging AI-driven insights from NexGenAI Solutions Group. The initiative includes the development of a new state-of-the-art operational facility to support this next phase of growth.

Knightscope (NASDAQ: KSCP) has joined the Association for Uncrewed Vehicle Systems International (“AUVSI”), reinforcing its commitment to autonomous security innovation and federal policy leadership. The company will participate in AUVSI’s Cyber, Ground, and Defense Advocacy Committees, including a new Robotics Subcommittee focused on shaping a National Robotics Strategy. Knightscope plans to contribute its expertise in autonomous ground robotics and AI-driven public safety systems to help guide U.S. standards and legislation for uncrewed technologies.

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, posted record first quarter 2025 revenue of $15 million, up 509% from the prior year. Business and financial results for the quarter included the first Advantage annealing quantum computer sale and publication of breakthrough research demonstrating quantum supremacy on a real-world problem.

Last week saw the price of gold hit $3,400 per troy ounce as the dollar saw its value diminish, driven by growing concerns over geopolitical tensions and shifting global trade dynamics. Despite the closure of the London Bullion Market and Shanghai Gold Exchange for May Day celebrations, the rally in gold prices continued worldwide, reflecting increased investor demand for safe haven assets.

For many years, global human development showed consistent progress, and experts from the United Nations had once forecasted that by 2030, people worldwide would experience substantial improvements in their quality of life. However, recent events have changed that outlook. A series of major disruptions—most notably the COVID-19 pandemic—have caused setbacks in development across all parts of the world.

Medulloblastoma is a commonly occurring pediatric brain cancer in kids and adolescents. The cancer develops within the cerebellum, the part of the brain responsible for coordinating movement and other functions. These tumors enlarge quickly, can grow into nearby tissues, and in some cases, can metastasize. The variations in these tumors make it challenging to find appropriate treatments.

German automaker Audi registered a notable increase in vehicle sales in the first quarter of the year, thanks to the growing popularity of its battery electric vehicle (BEV) models. The carmaker’s Q1 2025 earnings report showed revenue of $16.6 billion, a 12.4% increase from Audi’s reported revenue in Q1 2024.

Standard Lithium (NYSE American: SLI) reported Q1 2025 results and highlighted major progress on its flagship Southwest Arkansas Project, including finalizing a $225 million U.S. Department of Energy grant and securing unanimous approval for its first brine production unit. The project was also designated a priority under Executive Order 14241 to boost American mineral production. In partnership with Equinor under the newly branded Smackover Lithium joint venture, the company completed final field-pilot testing with over 99% lithium recovery. With $31.6 million in cash and no debt, the company remains on track for further permitting and royalty approvals in Q2.